Wolf Ondracek (1953) completed his masters in Social Sciences at the Free University in Amsterdam in 1977 and his masters in Japanese Studies at Leiden University in 1988. After working as a researcher at the Center for Non-Western Studies of Leiden University he worked for several Japanese companies. His career in clinical drug development started in 1996 when he joined the Dutch CRO Mirai, where he set up a Japan Desk to serve Japanese customers. Subsequently he worked for Parexel International. In 2000 he set up his own consultancy company. From that time an intensive collaboration with CHDR was started and together with Adam Cohen he worked on establishing an infrastructure for bridging studies between Japanese and Caucasian subjects. In 2006 he became general manager of Promasys, CHDR's subsidiary that develops a unique clinical data management system. In 2008 he was involved in the founding of Julius Clinical Research, an epidemiology focused academic CRO for late phase clinical trials. In 2010 he returned in his position of general manager of Promasys. Since early 2011 he also became responsible for CHDR's marketing and business development activities.